Stephane Bancel, Chief Executive Officer at Moderna, Inc. (MRNA), sold 160,000 shares at $125.32 ($20.4M) on 2023-06-14, disclosed to the SEC on 2023-06-16.
Scheduled sale ($20.4M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.32 | 10,642 | $1.3M | 6.5% |
| 2 | $125.32 | 10,642 | $1.3M | 6.5% |
| 3 | $126.10 | 20,848 | $2.6M | 12.9% |
| 4 | $126.10 | 20,848 | $2.6M | 12.9% |
| 5 | $127.25 | 8,510 | $1.1M | 5.3% |
| 6 | $127.25 | 8,510 |
| $1.1M |
| 5.3% |
| 7 | $125.61 | 4,788 | $601K | 3.0% |
| 8 | $125.61 | 4,788 | $601K | 3.0% |
| 9 | $127.01 | 5,377 | $683K | 3.4% |
| 10 | $127.01 | 5,377 | $683K | 3.4% |
| 11 | $127.99 | 8,443 | $1.1M | 5.3% |
| 12 | $127.99 | 8,443 | $1.1M | 5.3% |
| 13 | $129.12 | 7,115 | $919K | 4.5% |
| 14 | $129.12 | 7,115 | $919K | 4.5% |
| 15 | $129.77 | 14,277 | $1.9M | 9.1% |
| 16 | $129.77 | 14,277 | $1.9M | 9.1% |
| Total | $127.27 avg | 160,000 | $20.4M | 100% |
| Filing → |
| MRNA | SELL | 2024-02-16 | $4.7M | — | Filing → |
| MRNA | SELL | 2023-06-30 | $6.6M | — | Filing → |
| MRNA | SELL | 2023-06-23 | $19.3M | — | Filing → |